Surgical Innovations Group (LSE:SUN) Change In Receivables : £-0.31 Mil (TTM As of Jun. 2024)

View and export this data going back to 1988. Start your Free Trial

What is Surgical Innovations Group Change In Receivables?

Surgical Innovations Group's change in receivables for the quarter that ended in Jun. 2024 was £-0.42 Mil. It means Surgical Innovations Group's Accounts Receivable increased by £0.42 Mil from Dec. 2023 to Jun. 2024 .

Surgical Innovations Group's change in receivables for the fiscal year that ended in Dec. 2023 was £0.03 Mil. It means Surgical Innovations Group's Accounts Receivable declined by £0.03 Mil from Dec. 2022 to Dec. 2023 .

Surgical Innovations Group's Accounts Receivable for the quarter that ended in Jun. 2024 was £2.44 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Surgical Innovations Group's Days Sales Outstanding for the six months ended in Jun. 2024 was 72.20.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Surgical Innovations Group's liquidation value for the six months ended in Jun. 2024 was £-0.37 Mil.

Surgical Innovations Group Change In Receivables Historical Data

The historical data trend for Surgical Innovations Group's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Surgical Innovations Group Change In Receivables Chart

Surgical Innovations Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

0.51

1.08

-0.41

-0.36

0.03

Surgical Innovations Group Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Change In Receivables	Get a 7-Day Free Trial															-0.36	-	-0.08	0.12	-0.42

Surgical Innovations Group Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was £-0.31 Mil.

Surgical Innovations Group (LSE:SUN) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Surgical Innovations Group's Days Sales Outstanding for the quarter that ended in Jun. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	2.443	/	6.175	*	91
=	72.20

2. In Ben Graham's calculation of liquidation value, Surgical Innovations Group's accounts receivable are only considered to be worth 75% of book value:

Surgical Innovations Group's liquidation value for the quarter that ended in Jun. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	0.232	-	4.089	+	0.75 * 2.443	+	0.5 * 3.3
=	-0.37

Surgical Innovations Group Change In Receivables Related Terms

Thank you for viewing the detailed overview of Surgical Innovations Group's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Surgical Innovations Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Surgical Innovations Group PLC (LSE:SUN) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

Clayton Wood House, 6 Clayton Wood Bank, Leeds, GBR, LS16 6QZ

Website

https://www.sigroupplc.com

Surgical Innovations Group PLC is involved in the design, development, manufacture, and sale of devices for use in minimally invasive surgery and equipment for precision engineering markets. The group sells branded products through independent healthcare distributors across the world and own-label products through original equipment manufacturer relationships. The SI Brand segment which derives key revenue, includes research, development, manufacture, and distribution of SI branded minimally invasive devices. The OEM segment includes the research, development, manufacture, and distribution of minimally invasive devices for third-party medical device companies through either own label or co-branding. The Distribution segment includes the distribution of specialist medical products.